Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 457.60
+30.20 (7.07%)
At close: Mar 27, 2026
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 106.71 billion as of March 27, 2026. Its market cap has increased by 86.61% in one year.
Market Cap
106.71B
Enterprise Value
101.83B
Revenue
2.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
457.60
Market Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 106.71B, an increase of 691.04%. That is a compound annual growth rate of 114.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 106.71B | 16.68% |
| Dec 31, 2025 | 91.46B | 146.43% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 240.33B |
| Innovent Biologics | 148.36B |
| WuXi Biologics | 133.89B |
| Akeso | 113.95B |
| Sino Biopharmaceutical | 104.08B |
| RemeGen | 64.84B |
| 3SBio | 54.25B |
| Biocytogen Pharmaceuticals (Beijing) | 36.79B |